Steven Singh

Summary

Country: USA

Publications

  1. pmc Costs and clinical consequences of suboptimal atrial fibrillation management
    Steven N Singh
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC, USA
    Clinicoecon Outcomes Res 4:79-90. 2012
  2. ncbi request reprint Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs
    Steven Singh
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Cardiovasc Pharmacol Ther 12:175-80. 2007
  3. ncbi request reprint Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy
    Steven N Singh
    Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Am Coll Cardiol 48:721-30. 2006
  4. ncbi request reprint Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation
    Steven Singh
    Veterans Affairs Center, Washington, USA
    J Interv Card Electrophysiol 10:71-6. 2004
  5. ncbi request reprint Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study
    Steven N Singh
    VA Medical Center, Washington, DC 20422, USA
    Card Electrophysiol Rev 7:225-8. 2003
  6. ncbi request reprint Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])
    Steven N Singh
    Division of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am J Cardiol 92:468-72. 2003
  7. ncbi request reprint The burden and management of TIA and stroke in the Veterans Administration and Department of Defense
    Steven N Singh
    Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA
    Am J Manag Care 15:S185-92. 2009
  8. doi request reprint Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial
    Steven N Singh
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Heart Rhythm 6:152-5. 2009
  9. doi request reprint A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure
    Peter Kokkinos
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    Blood Press 18:261-7. 2009
  10. doi request reprint Exercise capacity and mortality in hypertensive men with and without additional risk factors
    Peter Kokkinos
    Veterans Affairs Medical Center Cardiology Division, 50 Irving St, NW, Washington, DC 20422, USA
    Hypertension 53:494-9. 2009

Collaborators

Detail Information

Publications29

  1. pmc Costs and clinical consequences of suboptimal atrial fibrillation management
    Steven N Singh
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC, USA
    Clinicoecon Outcomes Res 4:79-90. 2012
    ..Additional research is necessary to compare treatment costs and outcomes of new versus existing agents; an immediate effort to optimize treatment based on existing evidence and guidelines is critical to reducing the burden of AF...
  2. ncbi request reprint Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs
    Steven Singh
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Cardiovasc Pharmacol Ther 12:175-80. 2007
    ....
  3. ncbi request reprint Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy
    Steven N Singh
    Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Am Coll Cardiol 48:721-30. 2006
    ..The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF...
  4. ncbi request reprint Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation
    Steven Singh
    Veterans Affairs Center, Washington, USA
    J Interv Card Electrophysiol 10:71-6. 2004
    ..Tedisamil is a complex class 3 agent, blocking multiple channels. Piboserod is a selective 5-HT receptor antagonist that is being investigated in clinical trials...
  5. ncbi request reprint Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study
    Steven N Singh
    VA Medical Center, Washington, DC 20422, USA
    Card Electrophysiol Rev 7:225-8. 2003
    ..Caution must be used when initiating dofetilide therapy to avoid torsade de pointes ventricular tachycardia, especially in patients with heart failure, hypertrophy, bradycardia and female gender...
  6. ncbi request reprint Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])
    Steven N Singh
    Division of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am J Cardiol 92:468-72. 2003
    ..SAFE-T had randomized 665 patients when enrollment terminated on October 31, 2001. Follow-up of patients continued until October 31, 2002, for a maximum period of 54 months and a minimum period of 12 months for all patients...
  7. ncbi request reprint The burden and management of TIA and stroke in the Veterans Administration and Department of Defense
    Steven N Singh
    Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA
    Am J Manag Care 15:S185-92. 2009
    ..In addition, the VA system avoids incentivizing physicians for performing medical services, and instead incentivizes quality of care, which may provide a further advantage for patients treated within that system...
  8. doi request reprint Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial
    Steven N Singh
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Heart Rhythm 6:152-5. 2009
    ..Energy levels for electrocardioversion in atrial fibrillation (AF) have been empiric, and the influence of antiarrhythmic therapy compared with placebo is largely unknown...
  9. doi request reprint A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure
    Peter Kokkinos
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    Blood Press 18:261-7. 2009
    ..Thus, we evaluated the association of exercise capacity and all-cause mortality in individuals with high-normal blood pressure...
  10. doi request reprint Exercise capacity and mortality in hypertensive men with and without additional risk factors
    Peter Kokkinos
    Veterans Affairs Medical Center Cardiology Division, 50 Irving St, NW, Washington, DC 20422, USA
    Hypertension 53:494-9. 2009
    ..The increased risk imposed by low fitness and additional cardiovascular risk factors was eliminated by relatively small increases in exercise capacity and declined progressively with higher exercise capacity...
  11. doi request reprint Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository
    Ross D Fletcher
    Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA
    Circulation 125:2462-8. 2012
    ..This study was designed to assess improvement in blood pressure control over a 10-year period in a large cohort of patients in the Department of Veterans Affairs...
  12. doi request reprint Exercise capacity and all-cause mortality in prehypertensive men
    Peter Kokkinos
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC, USA
    Am J Hypertens 22:735-41. 2009
    ..Increased exercise capacity is associated with lower mortality risk, but little is known about its effects in prehypertensives. Thus, we evaluated the association between exercise capacity and all-cause mortality in prehypertensives...
  13. pmc Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes
    Peter Kokkinos
    Veterans Affairs Medical Center, Washington, DC, USA
    Diabetes Care 32:623-8. 2009
    ..The purpose of this study was to assess the association between exercise capacity and mortality in African Americans and Caucasians with type 2 diabetes and to explore racial differences regarding this relationship...
  14. doi request reprint Exercise capacity and mortality in black and white men
    Peter Kokkinos
    Veterans Affairs Medical Center Cardiology Department, 50 Irving St NW, Washington, DC 20422, USA
    Circulation 117:614-22. 2008
    ..Exercise capacity is inversely related to mortality risk in healthy individuals and those with cardiovascular diseases. This evidence is based largely on white populations, with little information available for blacks...
  15. ncbi request reprint Exercise capacity and blood pressure associations with left ventricular mass in prehypertensive individuals
    Peter Kokkinos
    Veterans Affairs Medical Center, Cardiology Division, Washington, DC 20422, USA
    Hypertension 49:55-61. 2007
    ....
  16. ncbi request reprint Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T)
    J Edwin Atwood
    Cardiology Division, Walter Reed Army Medical Center, 6900 Georgia Ave NW, Washington, DC 20307, USA
    Am Heart J 153:566-72. 2007
    ..Therapy for chronic atrial fibrillation (AF) focuses on rate versus rhythm control, but little is known about the effects of common therapeutic interventions on exercise tolerance in AF...
  17. ncbi request reprint Amiodarone versus sotalol for atrial fibrillation
    Bramah N Singh
    Department of Veterans Affairs Medical Center, West Los Angeles, Calif 90073, USA
    N Engl J Med 352:1861-72. 2005
    ..The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial...
  18. doi request reprint Intrathoracic impedance preceding ventricular tachyarrhythmia episodes
    Hans J Moore
    Washington Veterans Affairs Medical Center, Washington, DC, USA
    Pacing Clin Electrophysiol 33:960-6. 2010
    ..We hypothesized that VT/VF episodes are preceded by decreases in intrathoracic impedance. The goal was to identify the relationship of intrathoracic impedance measured by implanted cardioverter defibrillators to the occurrence of VT/VF...
  19. ncbi request reprint Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure
    Steven N Singh
    Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am Heart J 152:974.e7-11. 2006
    ..The aim of the study was to determine the role of amiodarone or implantable cardioverter/defibrillator (ICD) in patients with AF and heart failure...
  20. ncbi request reprint Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery
    Jennifer Zimmer
    Department of Cardiology, Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am J Cardiol 91:1137-40. 2003
  21. ncbi request reprint QRS duration and mortality in patients with congestive heart failure
    Stephen Iuliano
    Veterans Affairs and Georgetown University Medical Centers, Washington, DC 20422, USA
    Am Heart J 143:1085-91. 2002
    ..The purpose of this study was to examine the association between QRS duration and survival in patients with heart failure...
  22. ncbi request reprint Nonsustained ventricular tachycardia in dilated cardiomyopathy
    Frank A Cuoco
    Department of Cardiology, Veterans Affairs Medical Center, 4A107, 50 Irving Street, NW, Washington, DC 20422, USA
    Curr Cardiol Rep 7:368-75. 2005
    ..This article focuses on the prognostic significance and treatment of patients with NSVT and ischemic or nonischemic dilated cardiomyopathy...
  23. ncbi request reprint Exercise capacity and 24-h blood pressure in prehypertensive men and women
    Peter Kokkinos
    Veterans Affairs Medical Center Cardiology Division, Washington, DC Georgetown University Medical Center, Washington, DC, USA
    Am J Hypertens 19:251-8. 2006
    ..Physically active, normotensive individuals are also at lower risk for developing hypertension than sedentary individuals. We assessed the relationship between fitness and 24-h ambulatory BP in prehypertensive men and women...
  24. doi request reprint Pseudoaneurysm of mitral-aortic intervalvular fibrosa: two case reports and review of literature
    Thaslim Ahamed Kassim
    Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue, NW, Washington, DC 20060, USA
    Eur J Echocardiogr 11:E7. 2010
    ..Pseudoaneurysm of the mitral-aortic intervalvular fibrosa is a rare complication of infective endocarditis, but delay in diagnosis can lead to devastating outcome...
  25. ncbi request reprint Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)
    Kenneth C Bilchick
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Cardiol 90:24-8. 2002
    ..3 ms had a significantly increased risk of sudden death (p = 0.016). Thus, HRV was the sole independent predictor of overall mortality and was significantly associated with sudden death in this population...
  26. ncbi request reprint Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation
    Elizabeth L Batcher
    West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif, USA
    Am J Med 120:880-5. 2007
    ..The purpose of this study was to determine the extent of amiodarone-induced thyroid dysfunction in a large male cohort...
  27. ncbi request reprint The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial
    Craig M Pratt
    The Methodist DeBakey Heart Center and Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Am Coll Cardiol 43:1211-6. 2004
    ....
  28. ncbi request reprint Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Am Heart J 149:548-57. 2005
    ..The aims of these subanalyses of Val-HeFT were to assess (a) the effects of valsartan in the prevention of AF, (b) the independent predictors of this event, and (c) the prognostic role of AF occurrence...
  29. ncbi request reprint Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects
    Dougal R McClean
    Christchurch Hospital, Christchurch, New Zealand
    J Am Coll Cardiol 39:2034-41. 2002
    ..We investigated the acute and long-term hemodynamic and neurohumoral effects of the vasopeptidase inhibitor omapatrilat in human heart failure...